In the epilepsy susceptibility test, overexpression of CXCL12 prolonged the latency and increased cumulative doses of PTZ to induce tonic-clonic seizures (Fig. 7D–G), rescuing the increased epilepsy susceptibility caused by prenatal sevoflurane exposure. The gene discussed is CXCL12; the disease is Bilateral tonic-clonic seizure.